Zdrowie i gospodarka · 21/11/1997

FDA Clears Way for Generic Desmopressin Acetate Nasal Solution

The US Food and Drug Administration (FDA) has determined that desmopressin acetate nasal solution 0.01% (for refrigerated storage), commonly sold under the brand name DDAVP Nasal Spray, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for generic versions to be approved.